Daniel Umbricht

Focus on early clinical development and experimental medicine and translational neuroscience approaches. Successfully led the early clinical development of compounds in schizophrenia, autism, and major depression. He is currently the head of the psychiatry/neurodevelopmental group in translational medicine neuroscience at Roche.